We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$280M
AUM Growth
-$22.4M
Cap. Flow
+$12.3M
Cap. Flow %
4.39%
Top 10 Hldgs %
45.13%
Holding
86
New
11
Increased
25
Reduced
35
Closed
10

Top Buys

Rank Stock Value
1
JPM.WS
JPMorgan Chase
JPM.WS
+$16.1M
2
GILD icon
Gilead Sciences
GILD
+$7.44M
3
F icon
Ford
F
+$4.89M
4
EWK icon
iShares MSCI Belgium ETF
EWK
+$2.36M
5
ISRG icon
Intuitive Surgical
ISRG
+$2.08M

Top Sells

Rank Stock Value
1
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$5.04M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.58M
3
ABMD
Abiomed Inc
ABMD
+$3.46M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.44M
5
LOW icon
Lowe's Companies
LOW
+$3.02M

Sector Composition

Rank Sector Weight
1 Healthcare 27.66%
2 Financials 12.12%
3 Energy 11.81%
4 Communication Services 9.71%
5 Consumer Discretionary 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISRG icon
1
Intuitive Surgical
ISRG
$119B
$21.6M 7.71%
293,868
+26,298
+10% +$2.08M
MA icon
2
Mastercard
MA
$469B
$19.7M 7.03%
223,439
+2,110
+1% +$231K
CELG
3
DELISTED
Celgene Corp
CELG
$14M 5%
141,822
-380
-0.3% -$45.5K
JPM.WS
4
DELISTED
JPMorgan Chase
JPM.WS
$13.3M 4.76%
657,727
+345,725
+111% +$16.1M
META icon
5
Meta Platforms (Facebook)
META
$1.54T
$12.6M 4.5%
110,175
+340
+0.3% +$45.4K
AAPL icon
6
Apple
AAPL
$4.72T
$11.4M 4.09%
478,744
-54,260
-10% -$1.79M
BMY icon
7
Bristol-Myers Squibb
BMY
$126B
$9.15M 3.27%
124,367
+17,539
+16% +$962K
GILD icon
8
Gilead Sciences
GILD
$162B
$8.83M 3.15%
+105,815
New +$7.44M
JPM icon
9
JPMorgan Chase
JPM
$930B
$8.06M 2.88%
129,745
+2,332
+2% +$206K
IDXX icon
10
Idexx Laboratories
IDXX
$42.5B
$7.68M 2.74%
82,691
+945
+1% +$130K
SLB icon
11
SLB Ltd
SLB
$70.6B
$7.63M 2.72%
96,065
-1,509
-2% -$123K
FANG icon
12
Diamondback Energy
FANG
$57.8B
$6.5M 2.32%
71,215
-2,587
-4% -$267K
PCRX icon
13
Pacira BioSciences
PCRX
$1.02B
$5.55M 1.98%
164,622
+22,149
+16% +$957K
BAC.WS.A
14
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
$5.31M 1.9%
1,526,280
-37,575
-2% -$431K
CLB icon
15
Core Laboratories
CLB
$544M
$5.29M 1.89%
42,657
-1,770
-4% -$206K
UAA icon
16
Under Armour
UAA
$2.87B
$5.27M 1.88%
131,280
+58,415
+80% +$1.36M
F icon
17
Ford
F
$56.4B
$5.26M 1.88%
413,351
+393,351
+1,967% +$4.89M
VFC icon
18
VF Corp
VFC
$6.49B
$5.25M 1.87%
90,601
-1,026
-1% -$50.6K
GOOGL icon
19
Alphabet (Google) Class A
GOOGL
$3.88T
$5.15M 1.84%
146,500
-81,860
-36% -$3.44M
LMT icon
20
Lockheed Martin
LMT
$131B
$5.11M 1.83%
20,461
+3,013
+17% +$789K
CVX icon
21
Chevron
CVX
$387B
$5.07M 1.81%
47,893
-754
-2% -$84.6K
ILMN icon
22
Illumina
ILMN
$29.8B
$4.51M 1.61%
33,015
-5,174
-14% -$815K
PM icon
23
Philip Morris
PM
$298B
$4.33M 1.55%
42,583
-808
-2% -$83.4K
VZ icon
24
Verizon
VZ
$183B
$4.31M 1.54%
77,129
-10,339
-12% -$519K
GIS icon
25
General Mills
GIS
$19B
$4.06M 1.45%
56,869
-1,392
-2% -$85.1K
1
2 3 4

Similar funds

LA
Lifeworks Advisors Grand Rapids, Michigan $779M AUM 21.25% 1-Year Est. Return
UBV
United Bank (Virginia) Vienna, Virginia $781M AUM 27.1% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
RTM
RH Tailwind Management West Conshohocken, Pennsylvania $781M AUM
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return
QCMNJ
Quantum Capital Management (New Jersey) Northfield, New Jersey $781M AUM 4.96% 1-Year Est. Return
TIS
Titan Investment Solutions London $781M AUM
MO
McMillan Office St. Clair Shores, Michigan $782M AUM

Biondo Investment Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Biondo Investment Advisors held 86 positions worth $280M, down 7.4% from $302M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Biondo Investment Advisors deployed $12.3M of net new capital in Q1 2017, opening 11 new positions and adding to 25 existing holdings. Its largest new stake was Gilead Sciences: 105,815 shares worth $8.83M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $3.58M trimmed.

  • Biondo Investment Advisors's largest Q1 2017 buy was Gilead Sciences: 105,815 shares worth $8.83M.
  • Biondo Investment Advisors added most to JPMorgan Chase in Q1 2017, an estimated $16.1M increase.
  • Biondo Investment Advisors's biggest Q1 2017 reduction was Regeneron Pharmaceuticals, cutting an estimated $3.58M.
  • Biondo Investment Advisors fully exited Eagle Pharmaceuticals, Inc. in Q1 2017, selling an estimated $5.04M.
  • Biondo Investment Advisors's ten largest holdings make up 45% of its $280M portfolio in Q1 2017.
  • Biondo Investment Advisors opened 11 new positions and closed 10 in Q1 2017.
  • Biondo Investment Advisors's portfolio value fell 7.4% quarter-over-quarter to $280M.

Based on Biondo Investment Advisors's 13F filing for Q1 2017, filed 1 May 2017.